These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32936748)

  • 1. Treatment innovation for patients: a collaborative network in the Benelux and an inside view of 20 years of Galapagos.
    Durez P; Hoekema A; Huizinga T; Gazin M; Present E; Veelaert D; Wigerinck P; Westhovens R
    Acta Clin Belg; 2022 Feb; 77(1):233-240. PubMed ID: 32936748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Policy Framework for Health Systems to Promote Triple Aim Innovation.
    Verma A; Bhatia S
    Healthc Pap; 2016; 15(3):9-23. PubMed ID: 27009582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and investing in healthcare innovation and collaboration.
    Day-Duro E; Lubitsh G; Smith G
    J Health Organ Manag; 2020 Apr; ahead-of-print(ahead-of-print):. PubMed ID: 32250574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
    Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
    Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
    Dhainaut JF; Blin O; Herry F; ; Benito S; Bilbault P; Cauterman M; Favrel-Feuillade F; Fazi-Leblanc S; Germain C; Goehrs C; Grosskopf C; Labarthe B; Lechat P; Malciu C; Marquet P; Miceli-Richard C; Peyret O; Rattenbach R; de Saint-Exupéry E
    Therapie; 2020; 75(1):113-123. PubMed ID: 31948660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
    Hassan IF; Alinier G
    Qatar Med J; 2019; 2019(2):1. PubMed ID: 31763204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial aspects and the future of the pharmaceutical industry in the United States of america.
    Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
    Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helping science and drug development to succeed through pharma-academia partnerships: Yale Healthcare Conference 2013.
    Yang DX; Kim YA
    Yale J Biol Med; 2013 Sep; 86(3):429-32. PubMed ID: 24058318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Systems Innovation at Academic Health Centers: Leading in a New Era of Health Care Delivery.
    Ellner AL; Stout S; Sullivan EE; Griffiths EP; Mountjoy A; Phillips RS
    Acad Med; 2015 Jul; 90(7):872-80. PubMed ID: 25738387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative healthcare research: some ethical considerations.
    Raza M
    Sci Eng Ethics; 2005 Apr; 11(2):177-86. PubMed ID: 15915858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.